Research news
The latest developments in the search for better treatments and a cure for macular disease.
Latest news
Volunteers needed to try new drug for late-stage dry AMD
Posted: Thursday 5 June 2025
A company developing a new treatment for late-stage dry age-related macular degeneration (AMD) is looking for volunteers in the UK to take part in a new trial.
How are new treatments developed?
Posted: Monday 28 April 2025
Developing new treatments for macular disease is a lengthy process involving many steps. From understanding the causes of a condition, to finding new treatments to test, and finally, going through the stages of clinical trials.
Professor Andrew Lotery answers your questions
Posted: Wednesday 5 March 2025
Professor Andrew Lotery discusses the latest approved treatment for wet age-related macular degeneration (AMD), Lytenava and answers your frequently asked questions on treatments and research.
Gene therapy trial improves sight in blind toddlers
Posted: Tuesday 4 March 2025
Four toddlers born with a severe form of childhood blindness have experienced “life-changing improvements” to their sight after participating in an experimental gene therapy trial.
Syfovre FAQs and next steps for dry AMD and geographic atrophy treatment
Posted: Thursday 30 January 2025
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) decision to reject the first potential treatment for geographic atrophy (GA), or late-stage age-related macular degeneration (AMD) is undoubtedly a disappointing one for those living with the condition. But, what does the decision mean? We answer your questions.
First treatment for late-stage dry AMD rejected by UK drug regulator
Posted: Wednesday 22 January 2025
The first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration has been rejected by the Medicines and Healthcare products Regulatory Agency (MHRA).
Explore our research
Beating macular disease through funding medical research and improving the lives of those living with macular disease.
Get involved in research
Patients have a very important part to play in medical research. Without them we would not have the treatments we have today and new and improved treatments would not be possible.
Get the latest research news from the Macular Society
To hear about life-changing research and treatments, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter